Acrivon Therapeutics Inc (ACRV)

Dec 04, 2025

How Acrivon Therapeutics Inc. stock reacts to bond yieldsBond Market & AI Forecasted Entry and Exit Points - Newser

Dec 04, 2025

Dec 02, 2025

Get in on Acrivon Therapeutics Inc’s (ACRV) buy-in window today! - Setenews

Dec 02, 2025

Nov 29, 2025

H.C. Wainwright Initiates Coverage on Acrivon Therapeutics (ACRV) With “Buy” Rating and $19 PT - Insider Monkey

Nov 29, 2025

Nov 27, 2025

Investors in cash trouble should check out Acrivon Therapeutics Inc (ACRV) - Setenews

Nov 27, 2025

Nov 27, 2025

Acrivon Therapeutics Enhances Tumor-Specific Treatment Models - Kalkine Media

Nov 27, 2025

Nov 27, 2025

HC Wainwright Reiterates Buy Rating for Acrivon Therapeutics (NASDAQ:ACRV) - Defense World

Nov 27, 2025

Nov 26, 2025

Acrivon Therapeutics' (ACRV) "Buy" Rating Reiterated at HC Wainwright - MarketBeat

Nov 26, 2025

Nov 25, 2025

Citadel Advisors LLC Acquires Additional Shares in Acrivon Therapeutics Inc - GuruFocus

Nov 25, 2025

Nov 25, 2025

ACRV: HC Wainwright Reiterates 'Buy' Rating and $19 Price Target - GuruFocus

Nov 25, 2025

Nov 25, 2025

HC Wainwright & Co. Reiterates Acrivon Therapeutics (ACRV) Buy Recommendation - Nasdaq

Nov 25, 2025

Nov 25, 2025

Optimistic Buy Rating for Acrivon Therapeutics, Inc. Driven by Promising ACR-368 Trial Developments - TipRanks

Nov 25, 2025

Nov 21, 2025

Will Acrivon Therapeutics Inc. stock see PE expansionWeekly Trade Recap & High Accuracy Trade Alerts - newser.com

Nov 21, 2025

Nov 21, 2025

Research Analysts Issue Forecasts for ACRV FY2025 Earnings - Defense World

Nov 21, 2025

Nov 19, 2025

Brokerages Set Acrivon Therapeutics, Inc. (NASDAQ:ACRV) Target Price at $11.00 - Defense World

Nov 19, 2025

Nov 18, 2025

There is no way Acrivon Therapeutics Inc (ACRV) can keep these numbers up - Setenews

Nov 18, 2025

Nov 17, 2025

Acrivon Therapeutics stock rating reiterated by Citizens with $13 target - Investing.com Nigeria

Nov 17, 2025

Nov 16, 2025

Is Acrivon Therapeutics Inc. stock attractive for hedge fundsMarket Performance Recap & Capital Efficient Trade Techniques - newser.com

Nov 16, 2025

Nov 16, 2025

Will Acrivon Therapeutics Inc. stock split attract more investors2025 Momentum Check & Weekly Sector Rotation Insights - newser.com

Nov 16, 2025

Nov 16, 2025

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Intellia Therapeutics (NTLA) and Acrivon Therapeutics, Inc. (ACRV) - The Globe and Mail

Nov 16, 2025

Nov 14, 2025

Acrivon Therapeutics Narrows Losses And Draws Analyst Support - Finimize

Nov 14, 2025

Nov 14, 2025

Positive Outlook and Buy Rating for Acrivon Therapeutics, Inc. Based on Promising Clinical Data and Strategic Advancements - TipRanks

Nov 14, 2025

Nov 14, 2025

Acrivon Therapeutics Shrinks Losses And Draws Analyst Optimism - Finimize

Nov 14, 2025

Nov 14, 2025

Analysts’ Top Healthcare Picks: Acrivon Therapeutics, Inc. (ACRV), Sera Prognostics (SERA) - The Globe and Mail

Nov 14, 2025

Nov 14, 2025

Is Acrivon Therapeutics Inc. stock supported by strong cash flowsMarket Trend Report & Community Verified Watchlist Alerts - newser.com

Nov 14, 2025

Nov 14, 2025

Acrivon Therapeutics Reports Q3 2025 Financial Results - TipRanks

Nov 14, 2025

Nov 13, 2025

Acrivon Therapeutics Advances ACR-368 in Phase 2b Trial for Endometrial Cancer and Prepares for Initial Data on ACR-2316 - Quiver Quantitative

Nov 13, 2025

Nov 13, 2025

Acrivon Therapeutics Reports Third Quarter 2025 Financial Results and Business Highlights - Bluefield Daily Telegraph

Nov 13, 2025

Nov 13, 2025

Does Acrivon Therapeutics Inc (ACRV) offer a good opportunity for investors? - Setenews

Nov 13, 2025

Nov 12, 2025

Why Acrivon Therapeutics Inc. stock is recommended by analystsWeekly Risk Summary & Free Daily Entry Point Trade Alerts - newser.com

Nov 12, 2025

Nov 10, 2025

Acrivon Therapeutics (ACRV) Expected to Announce Quarterly Earnings on Wednesday - Defense World

Nov 10, 2025

Nov 09, 2025

Is Acrivon Therapeutics Inc. stock a contrarian buyQuarterly Market Summary & Free High Accuracy Swing Entry Alerts - newser.com

Nov 09, 2025

Nov 09, 2025

Will Acrivon Therapeutics Inc. stock benefit from green energy trendsWeekly Investment Report & Weekly Hot Stock Watchlists - newser.com

Nov 09, 2025

Nov 08, 2025

Acrivon Therapeutics (NASDAQ:ACRV) & Bioasis Technologies (OTCMKTS:BIOAF) Financial Analysis - Defense World

Nov 08, 2025

Nov 07, 2025

Custom strategy builders for tracking Acrivon Therapeutics Inc.Sell Signal & Precise Swing Trade Entry Alerts - newser.com

Nov 07, 2025

Nov 06, 2025

Acrivon Therapeutics reports preclinical data on ACR-2316 - BioWorld MedTech

Nov 06, 2025

Nov 06, 2025

Can Acrivon Therapeutics Inc. stock weather global recessionPortfolio Return Summary & Expert Approved Trade Ideas - newser.com

Nov 06, 2025